Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval
Emily K. Sims(University School), Jay M. Sosenko(University of Miami), Jay S. Skyler(University of Miami), Kevan C. Herold(Yale University), María J. Redondo(Baylor College of Medicine), Heba M. Ismail(Children's Hospital of Pittsburgh), Peter Taylor(University Hospital of Wales), Brandon M. Nathan(University of Minnesota), Alice L. J. Carr(University of Alberta), Alfonso Galderisi(University of Padua), David Cuthbertson(University of South Florida), William E. Russell(Vanderbilt University), Laura M. Jacobsen(University of Florida), Colin Dayan(University of Birmingham)
Cited by 1
Related Papers
An Essential Role for Ectodomain Shedding in Mammalian Development
|Science|1998|1.6k
Global epidemiology of hyperthyroidism and hypothyroidism
|Nature Reviews Endocrinology|2018|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
Diabetic Somatic Neuropathies
|Diabetes Care|2004|919